INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
70.16 |
74.65 |
57.52 |
|
81.47 |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
- |
- |
|
- |
Revenue Not From Contract With Customer |
0.09 |
0.08 |
0.06 |
|
0.11 |
Other Revenue |
21.73 |
23.08 |
17.58 |
|
22.67 |
Total Revenue |
91.98 |
97.81 |
75.15 |
96.47 |
104.25 |
Cost of Goods and Services Sold |
15.49 |
15.54 |
14.47 |
15.81 |
17.89 |
Gross
Profit |
76.50 |
82.28 |
60.68 |
76.04 |
86.36 |
Selling, Administration, Marketing |
6.77 |
6.26 |
6.18 |
15.04 |
7.56 |
Gain (Loss) on Disposition of Assets |
- |
- |
- |
29.71 |
167.80 |
Depriciation & Amortization |
13.79 |
14.01 |
13.67 |
13.79 |
14.90 |
Research & development |
- |
- |
- |
- |
- |
Asset Impairment Charges |
- |
- |
- |
0.09 |
10.02 |
Other operatinig exp. /-income |
46.99 |
48.15 |
43.50 |
110.40 |
-117.15 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Insured Event Gain Loss |
- |
- |
- |
-0.03 |
- |
Operating Lease Expense |
0.59 |
0.61 |
- |
-0.55 |
1.19 |
Total operating costs including COS |
83.62 |
84.57 |
77.81 |
87.61 |
102.21 |
Operating income/-loss
|
8.37 |
13.25 |
-2.66 |
8.86 |
2.04 |
Other Deductions / - Income |
Interest expense |
9.00 |
8.87 |
9.09 |
-37.62 |
11.33 |
Interest income |
-1.52 |
-1.70 |
-1.74 |
1.42 |
-0.10 |
Net interest expense/-income |
7.48 |
7.17 |
7.35 |
6.67 |
11.23 |
Extinguishment of Debt |
- |
-0.05 |
-0.01 |
-0.09 |
-17.96 |
Loss (Income) from Equity Method Investments |
- |
- |
- |
5.93 |
-0.48 |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Gain (Loss) on Contract Termination |
- |
- |
- |
- |
- |
Other loss/ -income |
0.88 |
0.00 |
-0.53 |
-30.57 |
-132.35 |
Income Loss From Continuing Operations Before Unconsolidated Joint Venture Investments Income Taxes Noncontrolling Interest |
-1.22 |
- |
- |
- |
- |
Gain Loss From Unconsolidated Joint Ventures Equity Method Investments |
-0.01 |
- |
- |
- |
- |
Total costs & expenses |
90.76 |
91.79 |
84.62 |
87.61 |
-37.34 |
Income /-loss before income taxes |
1.23 |
6.03 |
-9.47 |
36.17 |
141.59 |
Income taxes expenses/-benefit |
0.28 |
0.07 |
0.03 |
0.72 |
5.40 |
Income after income taxes |
0.95 |
5.96 |
-9.50 |
37.63 |
136.19 |
Net income/-loss
of other equity |
0.00 |
0.00 |
0.00 |
- |
0.00 |
Income/-loss
from cont. Ops. |
0.95 |
5.96 |
-9.50 |
37.63 |
136.19 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Impairment Of Discontinued Assets |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
0.95 |
5.96 |
-9.50 |
36.89 |
136.19 |
Noncontrolling interests |
0.63 |
0.00 |
-2.00 |
3.96 |
0.62 |
Prefered dividends |
-6.04 |
-6.04 |
-6.04 |
6.04 |
-6.04 |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-4.46 |
1.72 |
-14.94 |
26.88 |
115.48 |
EBIT |
8.71 |
13.20 |
-2.12 |
42.84 |
152.82 |
EBITD |
22.48 |
27.17 |
11.52 |
56.59 |
167.67 |
EBITDA |
23.12 |
27.82 |
12.21 |
57.26 |
168.64 |